Bharat biotech company Overview

Bharat Biotech’s research stems from the need to innovate and the necessity to address public health requirements of the developing nations, while adhering to IPR. Our business model is to support the advancement of technologies through strong collaborative research, and simultaneously support the establishment of strong innovative technology platforms for intellectual property reputed driven enterprise R&D.

1. www.bharatbiotech.com
Corporate Profile 2014

2. www.bharatbiotech.com
Fast Facts
Issues
Products
R&D Pipeline
Projects
Recognition
Executive Summary

3. www.bharatbiotech.com
Fast Facts

4. www.bharatbiotech.com
Fast Facts Issues Products R&D Pipeline Projects Recognition
Established : 1996
Promoters : Dr. Krishna & Ms. Suchitra Ella
Business Line : Vaccines and Bio-therapeutics
First Project : Hepatitis B Vaccine - US $ 3.5 Mn
Investment : Over US $ 150 Mn till date
Facility : One of the largest facilities in Asia
Personnel : 700 resources including scientists
Accreditations : Korean FDA, ANVISA, other Countries
Innovation : 50 Global patents
Vision
Mission
To offer affordable, safe
and effective healthcare
solutions to combat mankind's
most dreaded illnesses, and to
thus eradicate or at least control
their occurrence in the years to
come.
Developing next-generation
remedies through Genetic
Engineering Technologies so as to
create a healthier world.
Mission 7 Billion

5. www.bharatbiotech.com
Issues

6. www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Emerging Country Challenges
Lack of clarity on disease burden, public health focus & policies
NEGLECTED APPROACH

NEGLECTED DISEASES

1 TYPHOID
2 HEPATITIS
3 ROTA
4 SCHISTOSOMIASIS
5 E. COLI
6 CHOLERA
7 OTHER DIARRHEA
1 JE
2 DENGUE
3 CHIKUNGUNYA
4 MALARIA
5 TRYPANOSOMA
6 LEISHMANIA
7 FILARIA
POLITICAL
COMMITTMENT
SCIENTIFIC
COMMITTMENT
Fast Facts Issues

7. www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Thinking Future
Today’s neglected diseases - Tomorrow’s global diseases
1 PLAGUE
2 HIV
3 INFLUENZA
4 MALARIA
1 DENGUE
2 CHIKUNGUNYA
3 TRYPANOSOMA
4 LEISHMANIA
5 FILARIA
6 JAPANESE ENCEPHALITIS
Fast Facts Issues
•No DW manufactures develop new vaccines.
•Most DW manufactures are biogeneric players.
•DC manufactures follow MNCs.
•Our Mission is to change that mindset.
NEGLECTED DISEASES
GLOBAL DISEASES

8. www.bharatbiotech.com
Emerging Market Value Proposition
Bharat Biotech Strategy
Population
Birth Cohort
Health Care Budgets
Increasing
Health Care Budgets
Decreasing
Our growth path for
future is here
Emerging

6 Billion

125 Million

Low Value

High Volume
Products R&D Pipeline Projects Recognition Fast Facts Issues
Developed

0.75 Billion

7.5 Million

High Value

Low Volume

9. www.bharatbiotech.com
Products

10. www.bharatbiotech.com
JE Launch
The Union Health & Family Welfare Minister, Shri Ghulam Nabi Azad launching
Japanese Encephalitis vaccine on 04
th
October, 2013 in New Delhi
Products R&D Pipeline Projects Recognition Issues Fast Facts
Purified, Inactivated Japanese Encephalitis Vaccine
1
st
indigenously developed

11. www.bharatbiotech.com
TCV Launch
Products R&D Pipeline Projects Recognition Issues Fast Facts
Vi Capsular Polysaccharide Tetanus Toxoid Conjugate Vaccine
World’s 1
st
Clinically Proven Typhoid Conjugate Vaccine
Dr. Christian Loucq - International Vaccine Institute Director-General launching
Typhoid Conjugate Vaccine in Hyderabad on 26th August, 2013

12. www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Product Launches
Dr. A.P.J. Abdul Kalam
Former President of India, launching
Dr. John Robbins
Father of Polysaccharide Vaccine
National Institute of Health, USA, launching

Dr. Julie Gerberding
Former Director of the U.S. Centers for
Disease Control, launching
Issues Fast Facts

13. www.bharatbiotech.com
Vaccines
Wide Product Portfolio
S. No. Vaccine Brand
1 DPT+ Hep B + Hib Comvac 5 ®
2 DPT+ Hep B Comvac 4-Hb ®
3 DPT; TT, DT Comvac 3 ™
4 Hep B Revac B
+
®
5 Hep B Revac B mcf ®
6 Hib BioHib ™
7 Typhoid Typbar ®
8 Typhoid Typbar TCV ™
9 OPV Trivalent BIOPOLIO ®
10 OPV Monovalent Type-1 BIOPOLIO M1 ™
11 OPV Monovalent Type-3 BIOPOLIO M3 ™
12 OPV Bivalent BIOPOLIO B1/3 ™
13 JE Jenvac ®
Products R&D Pipeline Projects Recognition Issues Fast Facts
S. No. Vaccine Brand
1 Typhoid Typbar ®
2 Typhoid Typbar TCV ™
3 Rabies INDIRAB ®
4 Influenza HN VAC ™
5 JE Jenvac ®
S. No. Vaccine Brand
1 Typhoid Typbar ®
2 Typhoid Typbar TCV ™
3 Influenza HN VAC ™
4 JE Jenvac ®
Children & Adult
Traveler
Children

14. www.bharatbiotech.com
Bio-therapeutics
Wide Product Portfolio
Products R&D Pipeline Projects Recognition Issues Fast Facts
S. No. Bio-therapeutic Brand
1 Probiotic Yeast BIOGIT™
2
Recombinant Human Epidermal
Growth Factor
REGEN-D ®
3
Recombinant Human Epidermal
Growth Factor, Silver Sulfadiazine &
Chlorexidine Gluconate Cream
SLVRGEN ®
4 Zinc with ORS ZELECT ®

15. www.bharatbiotech.com
Product Distribution
More than 2 Billion doses delivered
Products R&D Pipeline Projects Recognition Issues Fast Facts

16. www.bharatbiotech.com
More than 2 Billion doses delivered
Products R&D Pipeline Projects Recognition Issues Fast Facts
Korea
Nepal
Philippines
Brazil
(ANVISA)
Sri Lanka
Saudi
Arabia
Colombia
(INVIMA)
Ghana
Kenya
Congo
Turkey
Kazakhstan
Uganda
Syria
Malawi
Ukraine
Belarus
Ivory Coast
Accreditation
Pakistan
Myanmar

17. www.bharatbiotech.com
R&D Pipeline

18. www.bharatbiotech.com
Products R&D Pipeline Projects Recognition
Pipeline Products
1
st
Time in the world Typhoid Conjugate Vaccine
S. No. Vaccines
Product
Development
Preclinical
Testing
Phase I Phase II Phase III
Commercial
License
1 Chikungunya 2017
2 Malaria PvRII 2017
3 Staph Aureus MRSA 2018
4 Human Papilloma Virus 2018
5 Acellular Pertussis 2016
6 Tetanus (Meat Free) 2016
7 S. Paratyphi 2018
8 NTS Conjugates 2018
9 Sabin IPV 2018
Therapeutics
Product
Development
Preclinical
Testing
Phase I Phase II Phase III
Commercial
License
1 THR-100 2015
2 Lysostaphin Topical 2015
3 Lysostaphin IV 2017
4 r Human Serum Albumin 2014
Issues Fast Facts

19. www.bharatbiotech.com
Projects

20. www.bharatbiotech.com
Recognition

21. www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects Recognition Issues Fast Facts
VOA awards 2013
most promising vaccines for paediatric
16th March, 2013
Pharma Bio World Award
Business Leader of the Year
Biotechnology 2011
Best R&D Company of the year 2010
by Pharmaceutical Leadership Summit

2010 Mumbai
National Technology
Award Govt of India 2006
Business Innovation Marico Foundation
& Business World 2006

22. www.bharatbiotech.com
Recognition of Achievements
Young Enterprising Company
Products R&D Pipeline Projects Recognition Issues Fast Facts
JRD TATA Best Entrepreneur award FICCI Award Excellence in Science
Best Performance in Technology
Marico Foundation Innovation Award
TDB National award
DBT-award for Product & Process

23. www.bharatbiotech.com
“Our mission is to address the health care needs of emerging markets,
drive innovation, be a front runner in research and development of
new vaccines and bio-therapeutics”
Mission 7 Billion
Dr. Krishna M. Ella
Chairman & Managing Director

24. www.bharatbiotech.com
Thank You
Address
Products R&D Pipeline Projects Recognition Issues Fast Facts
Bharat Biotech International Limited
Genome Valley, Shameerpet Mandal,
Ranga Reddy District - 500 078 Andhra Pradesh, India.

Tel.: [phone]
Fax: [phone]
[email protected]
www.bharatbiotech.com